Capital Performance Advisors »

Cullinan Oncology shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $217 13 16.77

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Vanguard Specialized Funds Div App Etf (VIG)
NVIDIA Corporation (NVDA)

View all positions for Capital Performance Advisors

Top funds holding Cullinan Oncology

MPM Oncology Impact Management
BVF
BlackRock
Deerfield Management Company
Vanguard Group
Citadel Advisors
Paradigm Biocapital Advisors
Franklin Resources
State Street Corporation
Alliancebernstein
Blue Owl Capital Holdings
OrbiMed Advisors
Rtw Investments
VR Adviser
Dimensional Fund Advisors

View all funds holding Cullinan Oncology